-
-
-
-
-
-
-
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
ADMA Biologics (ADMA) Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek, SC
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/28: (ADMA) (G) (GOOGL) Higher; (PLX) (PINS) (RRD) Lower (more...)
-
-
-
-
-
-
-
After-Hours Stock Movers 02/06: (ASRT) (PINS) (UBER) Higher; (ZGNX) (MYGN) (RESN) Lower (more...)
-
-
-
-
-
-
-
ADMA Biologics (ADMA) Reports Commercial Relaunch and First Commercial Sales of BIVIGAM
-
-
-
-
-
-
-
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
-
-
-
-
-
-
-
ADMA Biologics Reports First Quarter 2019 Financial Results
-
1,168,812 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

